Newegg Commerce Inc
Change company Symbol lookup
Select an option...
NEGG Newegg Commerce Inc
CHFI China Finance Inc
SU Suncor Energy Inc
CUBI Customers Bancorp Inc
SMIT Schmitt Industries Inc
BA Boeing Co
AMSWA American Software Inc
V Visa Inc
SVFB SVF Investment Corp 2
DMO Western Asset Mortgage Opportunity Fund Inc

Consumer Discretionary : Internet & Direct Marketing Retail | Small Cap Value
Company profile

Newegg Commerce, Inc. is a technology-focused e-commerce company in North America. The Company has developed an online marketplace that delivers value to consumers, brands, and sellers in the technology products sector. It operates business-to-consumer (B2C) platforms, business-to-business (B2B) operations, and other online platforms. Its B2C platform focuses on selling information technology (IT) products, through its platforms, namely Newegg.Com, Newegg.Ca, And Newegg Global. The Company’s B2B platform focuses on providing office and IT equipment, through its platform. Its platforms offer a suite of e-commerce solutions, including product listing, fulfillment, marketing, customer service and other value-added tools and services. The Company’s product categories offered through its platforms, such as computer system, components, electronics, gaming, networking and smart home, office solutions, software and services, automotive and industrial, and health and sports.

Closing Price
Day's Change
0.06 (3.06%)
B/A Size
Day's High
Day's Low

10-day average volume:

J&J stock rises after 2023 profit view tops analyst outlook

6:47 am ET January 24, 2023 (MarketWatch)

Johnson & Johnson (JNJ) stock rose 0.9% in premarket trades on Tuesday after the drug company's profit outlook for 2023 topped analyst estimates. J&J's fourth-quarter profit fell 25.7% to $3.52 billion, or $1.33 a share, from $4.74 billion, or $1.77 a share, in the year-ago period. The company's adjusted net income in the latest quarter totaled $2.35 a share, ahead of the Wall Street analyst estimate of $2.23 a share, according to FactSet data. The drug company's revenue fell 4.4% to $23.71 billion, slightly short of the Wall Street revenue target of $23.896 billion. Looking ahead, J&J said it expects full-year 2023 earnings of about $10.55 a share, or a range of $10.45 to $10.65 a share, ahead of the latest analyst estimate of $10.33 a share. Shares of J&J are up 0.4% in the past 12 months as of Monday's close, compared to a 2.1% drop by the Dow Jones Industrial Average over the same time period.

-Steve Gelsi


(END) Dow Jones Newswires

January 24, 2023 06:47 ET (11:47 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.